Status:
WITHDRAWN
Tear Film Markers in Dry Eye Syndrome
Lead Sponsor:
Vishal Jhanji
Collaborating Sponsors:
Sun Pharmaceutical Industries Limited
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Dry eye is the most common reason for visit to an ophthalmologist's office. The prevalence is on the rise and is mainly attributed to factors such as increased environmental pollution and contact lens...
Detailed Description
Subjects will be recruited based on their diagnosis of dry eyes and an estimate of the severity of the disease that would be made by the investigator based on the patient's history and clinical examin...
Eligibility Criteria
Inclusion
- Diagnosed with Dry Eye, but who have not been prescribed a drug to treat this condition.
- 18 years of age and older
- OSDI score \> 12
Exclusion
- Younger than 18 years of age.
- Any other associated eye diseases other than Dry Eye.
- Inability to understand and give informed consent.
- Patients diagnosed with Dry Eye who are already using Cequa.
Key Trial Info
Start Date :
December 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 8 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04515329
Start Date
December 8 2023
End Date
December 8 2023
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Eye Center
Pittsburgh, Pennsylvania, United States, 15213